Neuroscience

Through our deep and proven expertise within the neuroscience space and our dedicated expert team, HRW Synapse, we’ll help you improve the lives of patients with challenging and complex conditions and make your neuroscience assets a success.

Get in touch

HRW Synapse

Neuroscience is a competitive, complex, and diverse field that presents unique challenges for successful market research.

Challenges in neuroscience can include:

•  Forecasting usage of novel, pipeline products with new modes of action within underserved spaces

•  Connecting with vulnerable patients with psychiatric or neurodegenerative disorders

•  Differentiating within a congested market with complicated prescribing pattern

Achieving your objectives with often complex respondent groups – be they healthcare professionals, patients or carers – within the fast-evolving neuroscience market isn’t easy.

Neurodegenerative and psychiatric disorders are challenging to treat. Few conditions have a ‘one size fits all’ solution, with holistic care, personalised treatment options and the patient environment playing a significant role. 

As neuroscience specialists, we’ll bring our expertise to your project to ensure the idiosyncrasies of your therapy area are at the forefront of your research design and interpretation. 

Members of the HRW neuroscience market research team.
Union

The work of our specialist neuroscience team, HRW Synapse, is underpinned by integrated working with HRW’s expert Market Research teams in quant and qual, Behavioural Science, Data Science, and patient research.

Together, we equip you with an extensive suite of tools to use within your projects and we understand how these must be adapted for neuroscience to ensure they are appropriate and manageable.

So, we can provide you with the holistic expertise and consultancy within neuroscience you require and uncover the insights you need.

HRW researchers doing neuroscience market research.

How are we different? We are:

Neuroscience Experts
The HRW Synapse team combines academic qualifications and professional backgrounds within neuroscience. We prioritise our expertise in neuroscience across our organisation and as a result, a large proportion of our market research work is in the neuroscience field.
Always Evolving
Our commitment to the neuroscience field means we’re constantly investing in our expertise through internal upskilling and investment in learning in neuroscience and via external industry engagement, such as conferences, expert panel interviews, KOL interviews, webinars, and podcasts
Market Sensitive
Within the neuroscience field, there are many differences in the perception of disease areas or therapies according to market, territory or country. Our expertise means we are equipped to navigate the nuances of what can be a complicated and convoluted landscape.
Ethically Considered
Our team is familiar with all ethical approval processes (including IRB and exemption from MR) and is supported by HRW’s dedicated Compliance Team. You can feel confident in our ability to navigate the ethical considerations of the neuroscience space, including the need for sensitive moderating, patient orientation, safeguarding, and empathy.
Thought Leaders
We’ve won 12+ international awards, including the EphMRA Excellence in MR Award, Best Use of Innovation (BOBI awards) and Intellus Worldwide Impact Award, and delivered scores of industry abstracts and papers

Types of diseases within neuroscience we apply our market research work to:

Neurodegenerative Disorders
  • Multiple Sclerosis
  • Parkinson’s
  • Alzheimer’s Disease
  • Other dementia
  • Huntington’s
  • Epilepsy
Mood Disorders
  • Depression/MDD
  • Bipolar Disorder
Anxiety Disorders
  • GAD
  • PTSD
Personality Disorders
  • Schizophrenia/CIAS
  • Borderline Personality Disorder
Headaches and Pain
Migraine
Addiction
Other
  • Insomnia/Daytime Sleepiness
  • Brain Scanning/Radiopharmaceuticals

HRW Synapse Team

Img

Abigail Graham

Senior Research Manager - London
Abigail has worked on a plethora of mental health conditions and has deep knowledge in bipolar disorder, schizophrenia. She also has knowledge of upcoming treatments, including researching into the use ...
See Profile

Abigail Graham

Senior Research Manager - London
shorthand
Img

Alexandra Petrache

Senior Behavioural Science Analyst - Wallingford
Alex has a PhD in Neuroscience with a focus in Alzheimer's disease. Alex is part of our in-house behavioural science team, HRW Shift, and loves to combine her experience in ...
See Profile

Alexandra Petrache

Senior Behavioural Science Analyst - Wallingford
shorthand
Img

Catherine Harwood

Senior Director - London
Cathy heads up the Synapse team giving direction and spearheading the initiative across the company. She has embedded knowledge across an array of conditions including, Bipolar disorder, Borderline Personality disorder, ...
See Profile

Catherine Harwood

Senior Director - London
shorthand
Img

Dana Al-Juburi

Senior Research Executive - London
Dana has a passion for market research within neuroscience and psychiatry, and has recently gained experience working on novel and pipeline psychedelics for the treatment of TRD (treatment resistance depression) ...
See Profile

Dana Al-Juburi

Senior Research Executive - London
shorthand
Img

Esme Barrow-Williams

Senior Director - Wallingford
Esme collaborates with Cathy in spearheading the Synapse team. Esme has a BSc Hons in psychology and a keen interest in understanding client business needs and how to partner with ...
See Profile

Esme Barrow-Williams

Senior Director - Wallingford
shorthand
Img

Faye Holmes

Research Director - London
Faye is a research director and brings experience across a number of neurological conditions. This includes extensive knowledge on schizophrenia, PTSD and BoPD as well as Parkinson's Disease, Agitation in ...
See Profile

Faye Holmes

Research Director - London
shorthand
Img

Vincent Huart

Senior Research Manager - Wallingford
Vincent brings a wealth of neurology expertise. Having studied diseases of the nervous system as a major his experience including schizophrenia, rare neurological conditions and multiple sclerosis.
See Profile

Vincent Huart

Senior Research Manager - Wallingford
shorthand
Img

Lucy Wates

Director - London
Lucy was diagnosed with chronic migraines in 2018 and since then has been an online advocate in the migraine space. She is an online influencer with a blog reaching over 1,000 people ...
See Profile

Lucy Wates

Director - London
shorthand
Img

Rhiannon Phillips

Associate Director of Behavioural Science - London
Rhiannon has a wealth of knowledge in the mental health space which includes schizophrenia, PTSD and BoPD. Rhiannon has worked in the forefront of new assets and as part of ...
See Profile

Rhiannon Phillips

Associate Director of Behavioural Science - London
shorthand
Img

Rifah Nanjiba

Research Executive - Manhattan
Rifah recently gradated with a degree in Neuroscience where she focused on the reward pathways in the brain which surround addiction and ADHD. Rifah has also conducted her own research ...
See Profile

Rifah Nanjiba

Research Executive - Manhattan
shorthand
Img

Millie Morgan

Research Executive - London
Millie recently graduated from University College London where her MSci degree explored the impact of a variety of neurological and mental disorders, including chronic pain and general anxiety disorder (GAD). ...
See Profile

Millie Morgan

Research Executive - London
shorthand

Case-studies

  • Combining a qualitative and quantitative approach in Alzheimer’s to generate a patient pathway map and a robust segmentation

    Objectives

    Our client was preparing for the launch of their treatment for Agitation in Alzheimer’s Disease (AAD), for which they needed:

    • An understanding of the integrated primary care pathway 
    • A customer segmentation.

    Insights from this research were used to inform a global positioning, but also understand the local nuances. 

    Our Approach

    We conducted a multi-phase qualitative into qualitative project in EU5 markets with GPs, neurologists and psychiatrists

    • Fusion groups: mixed focus groups provided a comprehensive understanding of the role of various stakeholders and differences in their decision-making priorities
    • Pathway mapping: in-depth individual interviews mapped the integrated primary are pathway and gave depth on perceptions of a new treatment
    • Product Profile Testing: assessed benefits and watchpoints at both a functional and emotional level
    • Quantitative Segmentation Phase: taking an iterative approach, insights from the qualitative phase provided inputs into a quantitative segmentation approach
    Outcome
    • Provided a strong steer on launch strategy, with concrete recommendations for priorities in pre-launch market shaping
    • Provided a robust 4-solution segmentation with clear guidance on which segments to target and how to activate each segment
  • Using innovative methodologies to inform product positioning and lexicon in epilepsy

    Objectives
    • Whilst childhood epilepsy is treated with pharmacological therapy, there is evidence that a ketogenic diet therapy (KDT) can provide significant benefits. 
    • Our client wished to investigate how to increase uptake of this dietary treatment and to understand how to communicate to HCPs about this topic.
    Our Approach

    Behavioural science re-analysis of existing researchHRW Shift reviewed our client’s existing market research reports to identify underlying mechanisms behind behaviour and inform the design of subsequent research accordingly.

    QualieTM Customer survey: 

    • Phase one (Qualitative)online survey which includes video capture of 50 second clips reflecting personal perspectives relating to questions posed in the survey
    • Phase two (Quantitative)subsequent survey respondents take the survey. And for critical questions, this group view three videos from qual respondents that gave similar answers and rated agreement with the perspective in each video.

    Lexicon analysis: linguistic analysis of the spontaneous language used by respondents (qual) and validated as impactful (quant) to provide guidance one how to speak to HCPs about ketogenic diet as a viable option for treatment.​​

    Outcome
    • Provided the client with a clear strategic recommendations : priority barriers to overcome, language to use, attributes to prioritise, and framing that gains attention
    • Our clients used these insights to provide materials in neurologists’ calls, share patients type cues in published case studies and leverage emotional themes in messaging
  • Synergistic approach of qualitative research in MS and Behavioural Science providing strategic communication refinement

    Objectives
    • Our client was preparing to launch an innovative asset in multiple sclerosis and were developing a new scientific message platform for their product
    • Main objective was to identify which statements resonated most amongst HCPs to help support their new asset’s launch. Insights fed into communication strategy to help market the treatment
    • We conducted a multi-market qualitative interviews across EU5 markets, US and Canada with neurologists, MS nurse specialists and KOLs
    Approach
    • WATDIs: conducted 75-minute interviews with neurologists and where appropriate MS nurse specialists to identify and prioritize the most resonant statements across multiple product themes 
    • Specialist KOL interviews: supported the research with specialist KOL interviews to identify any knowledge gaps within statements which HCPs may need additional educational support with
    • TPP testing: as part of the research, we briefly tested our clients TPP to gain overall thoughts and provide context to the statements 
    • HRW Shift: In order to uncover behavioural biases including heuristics, fallacies, or discursive techniques that drive response, we applied our behavioural science team HRW Shift
    Outcome
    • Research uncovered stark knowledge gaps behind our client’s novel MoA  which need addressing
    • It stressed the importance of needing to develop additional materials to drive education to help uptake
    • Provided clear robust insights into which statements and sub- statements to focus on and derived actionable recommendation on how to overcome customer biases and heuristics at play

Contact us




    checkedI would like to receive news and information from HRW
    checkedI agree to the HRW privacy policy

    Cookies

    We use cookies to give you the best possible experience. We can also use it to analyze the behavior of users in order to continuously improve the website for you. Data Policy

    analytical Essential